Joanna Hester

• Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.

  Carroll RP. et al, (2013), Nephrol Dial Transplant, 28, 462 - 465

• Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.

  Milward K. et al, (2013), Transplantation, 95, 85 - 93

• IL-1RII expressed by human regulatory T cells: a decoy strategy to ensure regulation

  Hester J. and Wood KJ., (2012), IMMUNOLOGY, 137, 71 - 71

• Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

  Hester J. et al, (2012), Am J Transplant, 12, 2008 - 2016

• Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.

  Schiopu A. et al, (2012), Atherosclerosis, 223, 291 - 298

• B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells.

  Heidt S. et al, (2012), Am J Transplant, 12, 1784 - 1792

• Regulatory immune cells in transplantation.

  Wood KJ. et al, (2012), Nat Rev Immunol, 12, 417 - 430

• Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model.

  Issa F. et al, (2012), PLoS One, 7

• Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.

  Hester J. et al, (2011), Transplantation, 91, 744 - 750

• Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.

  Issa F. et al, (2010), Transplantation, 90, 1321 - 1327

• T regulatory cells and the control of alloimmunity: from characterisation to clinical application.

  Wieckiewicz J. et al, (2010), Curr Opin Immunol, 22, 662 - 668

• In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.

  Nadig SN. et al, (2010), Nat Med, 16, 809 - 813

• IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells.

  Wei B. et al, (2010), Am J Transplant, 10, 69 - 80

• Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG).

  Hak Ł. et al, (2009), J Interferon Cytokine Res, 29, 327 - 332

• NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

  Jarosz M. et al, (2009), Central-European Journal of Immunology, 34, 94 - 99

• Changes in number of NK cells after one year from coronary artery bypass graft

  Hak Ł. et al, (2009), Central-European Journal of Immunology, 34, 86 - 89

• Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

  Oliveira V. et al, (2008), Eur J Immunol, 38, 1677 - 1688

• Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.

  Trzonkowski P. et al, (2008), Am J Transplant, 8, 338 - 347

• Long-term prognosis after coronary bypass surgery depends on interleukin 6 polymorphism and past acute infections.

  Myśliwska J. et al, (2007), Int J Cardiol, 118, 421 - 422

• NK cell compartment in patients with coronary heart disease.

  Hak Ł. et al, (2007), Immun Ageing, 4

• Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries.

  Myśliwska J. et al, (2006), Eur Cytokine Netw, 17, 181 - 188

• High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus.

  Suchanek H. et al, (2005), Eur Cytokine Netw, 16, 177 - 185

• Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients.

  Trzonkowski P. et al, (2004), Brain Behav Immun, 18, 135 - 148

• Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence.

  Trzonkowski P. et al, (2003), Vaccine, 21, 3826 - 3836

• Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women.

  Rachoń D. et al, (2002), J Endocrinol, 172, 387 - 395

• Molecular cloning and sequencing of partial cDNA of tumor necrosis factor and p75 tumor necrosis factor receptor of Syrian golden hamster (Mesocricetus auratus) with the use of universal primers.

  Dobrzańska Z. et al, (2002), Acta Biochim Pol, 49, 427 - 431

Recent Publications

• Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.

  Carroll RP. et al, (2013), Nephrol Dial Transplant, 28, 462 - 465

• Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.

  Milward K. et al, (2013), Transplantation, 95, 85 - 93

• IL-1RII expressed by human regulatory T cells: a decoy strategy to ensure regulation

  Hester J. and Wood KJ., (2012), IMMUNOLOGY, 137, 71 - 71

• Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

  Hester J. et al, (2012), Am J Transplant, 12, 2008 - 2016

• Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.

  Schiopu A. et al, (2012), Atherosclerosis, 223, 291 - 298